Extended Use of Pharmaceutical GMP Facilities for Neutriceuticals Production

Published: 2004-12-13 07:00:00

Updated: 2004-12-13 07:00:00

The Ministry of Health and Welfare (MOHW) announced its allowance for the pharmaceutical companies to use their existing GMP-approved facilities to manufacture neutraceutical products as well.

Reflecting the MOHW’s efforts to foster and support the neutraceutical industry, the existing regulat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK